Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy

M. C. Park, YongBeom Park, S. Y. Jung, I. H. Chung, K. H. Choi, S. K. Lee

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

This study was designed to investigate the risk of ovarian failure and the pregnancy outcomes in women treated with intravenous cyclophosphamide (IVCYC) pulse therapy for lupus nephritis. Sixty-seven women with proliferative lupus nephritis were studied. The clinical and laboratory data, SLEDAI and damage indices at IVCYC initiation, doses and numbers of IVCYC pulses, pregnancy and fetal outcomes were evaluated. During a follow-up of 74.4 ± 20.6 months, amenorrhea occurred in 25 (37.3%) and was sustained permanently in 10 patients (14.9%). Thirteen women became pregnant with a total of 19 pregnancies. Seventeen pregnancies ended without complications and all babies were born healthy without any congenital anomalies or perinatal illnesses. Two pregnancies were terminated by induced abortion but no congenital anomaly was noted in these cases. Logistic regression analysis showed that old age, high damage index at the initiation of IVCYC pulse therapy and high cumulative dosage of IVCYC were the independent risk factors of ovarian failure, and that the presence of amenorrhea, regardless of its duration, was the risk factor of pregnancy failure. Pregnancy was possible with a favorable outcome after the withdrawal of IVCYC pulse therapy, unless amenorrhea develops.

Original languageEnglish
Pages (from-to)569-574
Number of pages6
JournalLupus
Volume13
Issue number8
DOIs
Publication statusPublished - 2004 Sep 9

Fingerprint

Lupus Nephritis
Pregnancy Outcome
Cyclophosphamide
Amenorrhea
Pregnancy
Therapeutics
Induced Abortion
Pregnant Women
Logistic Models
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology

Cite this

Park, M. C. ; Park, YongBeom ; Jung, S. Y. ; Chung, I. H. ; Choi, K. H. ; Lee, S. K. / Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. In: Lupus. 2004 ; Vol. 13, No. 8. pp. 569-574.
@article{f64cd918ef904edea0db958bc77e468b,
title = "Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy",
abstract = "This study was designed to investigate the risk of ovarian failure and the pregnancy outcomes in women treated with intravenous cyclophosphamide (IVCYC) pulse therapy for lupus nephritis. Sixty-seven women with proliferative lupus nephritis were studied. The clinical and laboratory data, SLEDAI and damage indices at IVCYC initiation, doses and numbers of IVCYC pulses, pregnancy and fetal outcomes were evaluated. During a follow-up of 74.4 ± 20.6 months, amenorrhea occurred in 25 (37.3{\%}) and was sustained permanently in 10 patients (14.9{\%}). Thirteen women became pregnant with a total of 19 pregnancies. Seventeen pregnancies ended without complications and all babies were born healthy without any congenital anomalies or perinatal illnesses. Two pregnancies were terminated by induced abortion but no congenital anomaly was noted in these cases. Logistic regression analysis showed that old age, high damage index at the initiation of IVCYC pulse therapy and high cumulative dosage of IVCYC were the independent risk factors of ovarian failure, and that the presence of amenorrhea, regardless of its duration, was the risk factor of pregnancy failure. Pregnancy was possible with a favorable outcome after the withdrawal of IVCYC pulse therapy, unless amenorrhea develops.",
author = "Park, {M. C.} and YongBeom Park and Jung, {S. Y.} and Chung, {I. H.} and Choi, {K. H.} and Lee, {S. K.}",
year = "2004",
month = "9",
day = "9",
doi = "10.1191/0961203304lu1063oa",
language = "English",
volume = "13",
pages = "569--574",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "8",

}

Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. / Park, M. C.; Park, YongBeom; Jung, S. Y.; Chung, I. H.; Choi, K. H.; Lee, S. K.

In: Lupus, Vol. 13, No. 8, 09.09.2004, p. 569-574.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy

AU - Park, M. C.

AU - Park, YongBeom

AU - Jung, S. Y.

AU - Chung, I. H.

AU - Choi, K. H.

AU - Lee, S. K.

PY - 2004/9/9

Y1 - 2004/9/9

N2 - This study was designed to investigate the risk of ovarian failure and the pregnancy outcomes in women treated with intravenous cyclophosphamide (IVCYC) pulse therapy for lupus nephritis. Sixty-seven women with proliferative lupus nephritis were studied. The clinical and laboratory data, SLEDAI and damage indices at IVCYC initiation, doses and numbers of IVCYC pulses, pregnancy and fetal outcomes were evaluated. During a follow-up of 74.4 ± 20.6 months, amenorrhea occurred in 25 (37.3%) and was sustained permanently in 10 patients (14.9%). Thirteen women became pregnant with a total of 19 pregnancies. Seventeen pregnancies ended without complications and all babies were born healthy without any congenital anomalies or perinatal illnesses. Two pregnancies were terminated by induced abortion but no congenital anomaly was noted in these cases. Logistic regression analysis showed that old age, high damage index at the initiation of IVCYC pulse therapy and high cumulative dosage of IVCYC were the independent risk factors of ovarian failure, and that the presence of amenorrhea, regardless of its duration, was the risk factor of pregnancy failure. Pregnancy was possible with a favorable outcome after the withdrawal of IVCYC pulse therapy, unless amenorrhea develops.

AB - This study was designed to investigate the risk of ovarian failure and the pregnancy outcomes in women treated with intravenous cyclophosphamide (IVCYC) pulse therapy for lupus nephritis. Sixty-seven women with proliferative lupus nephritis were studied. The clinical and laboratory data, SLEDAI and damage indices at IVCYC initiation, doses and numbers of IVCYC pulses, pregnancy and fetal outcomes were evaluated. During a follow-up of 74.4 ± 20.6 months, amenorrhea occurred in 25 (37.3%) and was sustained permanently in 10 patients (14.9%). Thirteen women became pregnant with a total of 19 pregnancies. Seventeen pregnancies ended without complications and all babies were born healthy without any congenital anomalies or perinatal illnesses. Two pregnancies were terminated by induced abortion but no congenital anomaly was noted in these cases. Logistic regression analysis showed that old age, high damage index at the initiation of IVCYC pulse therapy and high cumulative dosage of IVCYC were the independent risk factors of ovarian failure, and that the presence of amenorrhea, regardless of its duration, was the risk factor of pregnancy failure. Pregnancy was possible with a favorable outcome after the withdrawal of IVCYC pulse therapy, unless amenorrhea develops.

UR - http://www.scopus.com/inward/record.url?scp=4344672490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344672490&partnerID=8YFLogxK

U2 - 10.1191/0961203304lu1063oa

DO - 10.1191/0961203304lu1063oa

M3 - Article

VL - 13

SP - 569

EP - 574

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 8

ER -